Neurobiology of Schizophrenia Spectrum Disorders: The Role of Oxidative Stress

被引:0
作者
Wood, Stephen J. [1 ]
Yuecel, Murat [2 ]
Pantelis, Christos
Berk, Michael [2 ,3 ,4 ,5 ]
机构
[1] Univ Melbourne & Melbourne Hlth, Natl Neurosci Facil, Melbourne Neuropsychiat Ctr, Dept Psychiat, Carlton, Vic 3053, Australia
[2] Univ Melbourne, ORYGEN Res Ctr, Melbourne, Vic, Australia
[3] Barwon Hlth, Dept Clin & Biomed Sci, Geelong, Vic, Australia
[4] Univ Melbourne, Geelong Clin, Geelong, Vic, Australia
[5] Mental Hlth Res Inst, Melbourne, Vic, Australia
关键词
Glutathione; Magnetic resonance spectroscopy; N-acetyl cysteine; N-ACETYL-CYSTEINE; ETHYL-EICOSAPENTAENOIC ACID; POLYUNSATURATED FATTY-ACIDS; PLACEBO-CONTROLLED TRIAL; GLUTATHIONE-PEROXIDASE; 1ST-EPISODE PSYCHOSIS; PSYCHIATRIC-DISORDERS; CEREBROSPINAL-FLUID; LIPID-PEROXIDATION; THERAPEUTIC IMPLICATIONS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mitochondrial dysfunction and oxidative stress are increasingly implicated in the pathophysiology of schizophrenia. The brain is the body's highest energy consumer, and the glutathione system is the brain's dominant free radical scavenger. In the current paper, we review the evidence of central and peripheral nervous system anomalies in the oxidative defences of individuals with schizophrenia, principally involving the glutathione system. This is reflected by evidence of the manifold consequences of oxidative stress that include lipid peroxidation, protein carboxylation, DNA damage and apoptosis - all potentially part of the process of neuroprogression in the disorder. Importantly, oxidative stress is amenable to intervention. We consider the clinical potential of some possible interventions that help reduce oxidative stress, via augmentation of the glutathione system, particularly N-acetyl cysteine. We argue that a better understanding of the mechanisms and pathways underlying oxidative stress will assist in developing the therapeutic potential of this area.
引用
收藏
页码:396 / 401
页数:6
相关论文
共 69 条
[61]   Is the arginine-nitric oxide pathway involved in the pathogenesis of schizophrenia? [J].
Yanik, M ;
Vural, H ;
Kocyigit, A ;
Tutkun, H ;
Zoroglu, SS ;
Herken, H ;
Savas, HA ;
Köylü, A ;
Akyol, Ö .
NEUROPSYCHOBIOLOGY, 2003, 47 (02) :61-65
[62]   Altered glutathione redox state in schizophrenia [J].
Yao, Jeffrey K. ;
Leonard, Sherry ;
Reddy, Ravinder .
DISEASE MARKERS, 2006, 22 (1-2) :83-93
[63]   Abnormal age-related changes of plasma antioxidant proteins in schizophrenia [J].
Yao, JK ;
Reddy, R ;
van Kammen, DP .
PSYCHIATRY RESEARCH, 2000, 97 (2-3) :137-151
[64]   Increased nitric oxide radicals in postmortem brain from patients with schizophrenia [J].
Yao, JK ;
Leonard, S ;
Reddy, RD .
SCHIZOPHRENIA BULLETIN, 2004, 30 (04) :923-934
[65]   Oxidative damage and schizophrenia - An overview of the evidence and its therapeutic implications [J].
Yao, JK ;
Reddy, RD ;
van Kammen, DP .
CNS DRUGS, 2001, 15 (04) :287-310
[66]   Reduced status of plasma total antioxidant capacity in schizophrenia [J].
Yao, JK ;
Reddy, R ;
McElhinny, LG ;
van Kammen, DP .
SCHIZOPHRENIA RESEARCH, 1998, 32 (01) :1-8
[67]  
Yu WY, 2008, J PSYCHIATR NEUROSCI, V33, P244
[68]   Disrupted antioxidant enzyme activity and elevated lipid peroxidation products in schizophrenia patients with tardive dyskinesia [J].
Zhang, Xiang Yang ;
Tan, Yun Long ;
Zhou, Dong Feng ;
Cao, Lian Yuan ;
Wu, Gui Ying ;
Haile, Colin N. ;
Kosten, Theresa A. ;
Kosten, Thomas R. .
JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (05) :754-760
[69]   Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics [J].
Zhang, XY ;
Tan, YL ;
Cao, LY ;
Wu, GY ;
Xu, Q ;
Shen, Y ;
Zhou, DF .
SCHIZOPHRENIA RESEARCH, 2006, 81 (2-3) :291-300